Search research articles
Contact Us
Filters
Showing results (51-60 of 144) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Nature Genetics
|
June 7, 2011
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott, Marie Brevet, Barry S Taylor, et al.
Cancer Discovery
|
June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
Yijun Gao, Ann Maria, Na Na, et al.
Cancer Discovery
|
February 28, 2018
Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
Yijun Gao, Matthew T Chang, Daniel McKay, et al.
Cancer Research
|
June 23, 2011
Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma
Stacy Ugras, Elliott Brill, Anders Jacobsen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G T Morris, Barry S Taylor, Trever G Bivona, et al.
The Journal of Clinical Investigation
|
February 16, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2021
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
Catherine C Smith, Aaron D Viny, Evan Massi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2020
Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Tyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, et al.
Nature Communications
|
December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
Barbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 144) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Nature Genetics
|
June 7, 2011
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott, Marie Brevet, Barry S Taylor, et al.
Cancer Discovery
|
June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
Yijun Gao, Ann Maria, Na Na, et al.
Cancer Discovery
|
February 28, 2018
Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
Yijun Gao, Matthew T Chang, Daniel McKay, et al.
Cancer Research
|
June 23, 2011
Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma
Stacy Ugras, Elliott Brill, Anders Jacobsen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G T Morris, Barry S Taylor, Trever G Bivona, et al.
The Journal of Clinical Investigation
|
February 16, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2021
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
Catherine C Smith, Aaron D Viny, Evan Massi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2020
Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Tyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, et al.
Nature Communications
|
December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
Barbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Page
of 15